ETH Zurich Foundation, microcaps


Alessandro Ofner & Michael Hagander

Precise microencapsulation at industrial scale

Microcaps envisions to redefine precision standards on daily products in food, cosmetics, and pharma. For example, they envision to develop the new generation of drug delivery platforms.

This is enabled through their novel technology to produce size-controlled microparticles as carriers of medication, fragrances, or flavors.
The controlled microencapsulation allows to directly control the release, specifically tailor the uptake, and massively reduce unwanted side effects.

More on Microcaps on their website.